General Information of Drug (ID: DMHJOBQ)

Drug Name
N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide
Synonyms N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide; CHEMBL551683; AC1Q2ECP; AC1LEFA7; Oprea1_406651; ZINC102894; BDBM50297547; AKOS002953737; MCULE-2443287207; ST011073
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 325.1
Logarithm of the Partition Coefficient (xlogp) 4.2
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C14H10Cl2N2O3
IUPAC Name
N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide
Canonical SMILES
CC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-]
InChI
InChI=1S/C14H10Cl2N2O3/c1-8-2-3-9(6-13(8)18(20)21)14(19)17-12-5-4-10(15)7-11(12)16/h2-7H,1H3,(H,17,19)
InChIKey
VNKILQNNNYOVJY-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
711291
TTD ID
D0YK5U

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Fatty acid synthetase I (Bact inhA) TTVTX4N INHA_MYCTU Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30.